← back to search

Seth Flaxman

University of Oxford · GB
Area of research
Modeling and Simulation · Epidemiology
Research interest
Research interests include COVID-19 epidemiological studies, Ophthalmology and Visual Impairment Studies, SARS-CoV-2 and COVID-19 Research, and Gaussian Processes and Bayesian Inference.
h-index
74
citations
78,340
works
322
NIH funding
primary concept
Medicine
email

Recent publications

Artificial intelligence for modelling infectious disease epidemics
Nature 2025cited by 123position: middledoi
Effective refractive error coverage in adults: a systematic review and meta-analysis of updated estimates from population-based surveys in 76 countries modelling the path towards the 2030 global target
The Lancet Global Health 2025cited by 15position: middledoi
Global estimates on the number of people blind or visually impaired by glaucoma: A meta-analysis from 2000 to 2020
Eye 2024cited by 92position: middledoi
Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
Eye 2024cited by 91position: middledoi
Global estimates on the number of people blind or visually impaired by diabetic retinopathy: a meta-analysis from 2000 to 2020
Eye 2024cited by 60position: middledoi
Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020
Eye 2024cited by 41position: middledoi
Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020
Eye 2024cited by 29position: middledoi
Publisher Correction: Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
Eye 2024cited by 10position: middledoi
Ethnicity and anthropometric deficits in children: A cross-sectional analysis of national survey data from 18 countries in sub-Saharan Africa
PLOS Global Public Health 2024cited by 2position: middledoi
Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US
JAMA Network Open 2023cited by 137position: firstdoi
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
Northumbria Research Link (Northumbria University) 2022cited by 1,226position: middledoi
National, regional, and global estimates of anaemia by severity in women and children for 2000–19: a pooled analysis of population-representative data
The Lancet Global Health 2022cited by 466position: middledoi
Spatial and temporal fluctuations in COVID-19 fatality rates in Brazilian hospitals
Nature Medicine 2022cited by 61position: middledoi
Effective refractive error coverage in adults aged 50 years and older: estimates from population-based surveys in 61 countries
The Lancet Global Health 2022cited by 56position: middledoi
A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe
Scientific Data 2022cited by 11position: middledoi
Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Science 2021cited by 1,538position: middledoi
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England
Nature 2021cited by 1,296position: middledoi
Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study
The Lancet 2021cited by 294position: lastdoi
Unrepresentative big surveys significantly overestimated US vaccine uptake
Nature 2021cited by 248position: lastdoi
Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe
Nature Communications 2021cited by 228position: middledoi
Is the cure really worse than the disease? The health impacts of lockdowns during COVID-19
BMJ Global Health 2021cited by 109position: middledoi
Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria
Nature Communications 2021cited by 77position: middledoi
Vaccinating adolescents against SARS-CoV-2 in England: a risk–benefit analysis
Journal of the Royal Society of Medicine 2021cited by 43position: middledoi
Long COVID in children
The Lancet Child & Adolescent Health 2021cited by 14position: middledoi
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe
Nature 2020cited by 3,798position: firstdoi
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
The Lancet Global Health 2020cited by 2,977position: middledoi
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study
The Lancet Global Health 2020cited by 1,325position: middledoi
Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’
Nature 2020cited by 1,026position: middledoi
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study
The Lancet Infectious Diseases 2020cited by 217position: middledoi
State-level tracking of COVID-19 in the United States
Nature Communications 2020cited by 171position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 9 papers (2013–2018)Rupert Bourne · Portsmouth Hospitals NHS Trust9 papers (2013–2018)Konrad Pesudovs · Morpho (United States)9 papers (2013–2018)Janet L Leasher · Massachusetts Eye and Ear Infirmary9 papers (2013–2018)Hugh R. Taylor · The University of Melbourne9 papers (2013–2018)Jost B. Jonas · Addenbrooke's Hospital9 papers (2013–2018)Serge Resnikoff · UNSW Sydney9 papers (2013–2018)Richard White · University of Auckland8 papers (2012–2016)Samir Bhatt · University of Copenhagen8 papers (2021–2024)Tien Yin Wong · Neuroscience Research Australia7 papers (2014–2018)Majid Ezzati · Imperial College London6 papers (2012–2022)Kovin Naidoo · UNSW Sydney6 papers (2013–2018) · 6 papers (2013–2016)Swapnil Mishra · National University of Singapore5 papers (2021–2024)Oliver Ratmann · NIHR Imperial Biomedical Research Centre4 papers (2021–2023)Hans Limburg · London School of Hygiene & Tropical Medicine4 papers (2015–2018)Goodarz Danaei · Harvard University3 papers (2013–2015)Maria Vittoria Cicinelli · Vita-Salute San Raffaele University3 papers (2018–2018) · 3 papers (2018–2018)Deepti Gurdasani · Queen Mary University of London3 papers (2021–2023)